In the US, the drug Esmya is not available for use for fibroid treatment because the FDA deemed that its usage risks far outweighed the benefits of this uterine fibroid treatment drug. But elsewhere in the world including Europe and Canada, this prescription drug may be used for the treatment of uterine fibroids. Just like in Europe, Canada has decided to to restrict the use of Esmya for the treatment of uterine fibroids due to the risks of liver damage in some women who have liver problems.
In Canada, the drug is sold under the brand name Fibristal by pharmaceutical company Allergan.
Canada’s health regulator on Friday said it was restricting the use of Allergan Plc’s uterine fibroid treatment Esmya after discovering a risk of serious liver injury from the drug.
Health Canada said the drug, sold under brand name Fibristal in the country, should not be used by women with liver problems, or those who have had such problems in the past.
Fibristal should not be used in women who currently have, or have previously had liver problems, and intermittent use should be restricted to women of childbearing age who are not eligible for fibroid-removal surgery.
Patients taking Fibristal who develop symptoms such as fatigue, yellowing of the skin, darkening of the urine, or nausea and vomiting should stop taking the medication and contact their physician immediately.
Health Canada says doctors should not prescribe Fibristal to women with current or previous liver problems and they should advise patients of the need for monitoring their liver function before, during and after treatment.
While Esmya has been shown to help with uterine fibroids by blocking the action of the hormone progesterone, there are many risks because the liver damage mentioned above such as stopping the menstrual cycle, thickening the lining of the womb, etc, so it may be beneficial for you to look into various effective natural treatment methods included in this holistic guide.